Standout Papers
- Clinical development of platinum complexes in cancer therapy: an historical perspective and an update (1998)
- Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412 (2004)
- Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. (1987)
Immediate Impact
18 by Nobel laureates 28 from Science/Nature 66 standout
Citing Papers
Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future
2022 Standout
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Works of David Lebwohl being referenced
Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors
2008
Clinical development of platinum complexes in cancer therapy: an historical perspective and an update
1998 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David Lebwohl | 1126 | 1783 | 388 | 559 | 31 | 3.2k | |
| Peter Blume‐Jensen | 1249 | 3245 | 553 | 486 | 25 | 5.0k | |
| Stefan Hart | 1007 | 1393 | 267 | 320 | 30 | 2.7k | |
| Terence O’Reilly | 1115 | 1975 | 664 | 193 | 35 | 3.1k | |
| Ralf A. Hilger | 1207 | 1312 | 607 | 407 | 83 | 3.1k | |
| Paul Noordhuis | 1648 | 1315 | 493 | 338 | 81 | 3.3k | |
| Herman Burger | 1253 | 1156 | 327 | 519 | 44 | 2.6k | |
| Francis J. Giles | 761 | 1009 | 204 | 878 | 51 | 2.6k | |
| Lance Leopold | 1369 | 1086 | 429 | 473 | 50 | 2.7k | |
| Franca Stivala | 1578 | 3464 | 506 | 514 | 56 | 5.3k | |
| Michele McTigue | 994 | 1695 | 431 | 196 | 25 | 2.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...